79 related articles for article (PubMed ID: 17563765)
1. ABCB1 genetic polymorphism influences the pharmacology of the new pyrrolobenzodiazepine derivative SJG-136.
Aird RE; Thomson M; Macpherson JS; Thurston DE; Jodrell DI; Guichard SM
Pharmacogenomics J; 2008 Aug; 8(4):289-96. PubMed ID: 17563765
[TBL] [Abstract][Full Text] [Related]
2. Influence of P-glycoprotein expression on in vitro cytotoxicity and in vivo antitumour activity of the novel pyrrolobenzodiazepine dimer SJG-136.
Guichard SM; Macpherson JS; Thurston DE; Jodrell DI
Eur J Cancer; 2005 Aug; 41(12):1811-8. PubMed ID: 16046116
[TBL] [Abstract][Full Text] [Related]
3. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P
Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948
[TBL] [Abstract][Full Text] [Related]
5. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 2: efficacy evaluations.
Alley MC; Hollingshead MG; Pacula-Cox CM; Waud WR; Hartley JA; Howard PW; Gregson SJ; Thurston DE; Sausville EA
Cancer Res; 2004 Sep; 64(18):6700-6. PubMed ID: 15374987
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells.
Pepper C; Lowe H; Fegan C; Thurieau C; Thurston DE; Hartley JA; Delavault P
Br J Cancer; 2007 Jul; 97(2):253-9. PubMed ID: 17579621
[TBL] [Abstract][Full Text] [Related]
7. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
El-Khoury V; Breuzard G; Fourré N; Dufer J
Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922
[TBL] [Abstract][Full Text] [Related]
8. Preliminary pharmacokinetic and bioanalytical studies of SJG-136 (NSC 694501), a sequence-selective pyrrolobenzodiazepine dimer DNA-cross-linking agent.
Wilkinson GP; Taylor JP; Shnyder S; Cooper P; Howard PW; Thurston DE; Jenkins TC; Loadman PM
Invest New Drugs; 2004 Aug; 22(3):231-40. PubMed ID: 15122070
[TBL] [Abstract][Full Text] [Related]
9. Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: footprinting and enzyme inhibition studies.
Martin C; Ellis T; McGurk CJ; Jenkins TC; Hartley JA; Waring MJ; Thurston DE
Biochemistry; 2005 Mar; 44(11):4135-47. PubMed ID: 15766241
[TBL] [Abstract][Full Text] [Related]
10. Promoter polymorphisms and allelic imbalance in ABCB1 expression.
Loeuillet C; Weale M; Deutsch S; Rotger M; Soranzo N; Wyniger J; Lettre G; Dupré Y; Thuillard D; Beckmann JS; Antonarakis SE; Goldstein DB; Telenti A
Pharmacogenet Genomics; 2007 Nov; 17(11):951-9. PubMed ID: 18075465
[TBL] [Abstract][Full Text] [Related]
11. Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells.
Buys TP; Chari R; Lee EH; Zhang M; MacAulay C; Lam S; Lam WL; Ling V
Genes Chromosomes Cancer; 2007 Dec; 46(12):1069-79. PubMed ID: 17726699
[TBL] [Abstract][Full Text] [Related]
12. Disposition of a CYP2C9 phenotyping agent, losartan, is not influenced by the common 3435C > T variation of the drug transporter gene ABCB1 (MDR1).
Yasar U; Babaoglu MO; Bozkurt A
Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):176-9. PubMed ID: 18816302
[TBL] [Abstract][Full Text] [Related]
13. Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability.
Potocnik U; Glavac D; Dean M
Cancer Genet Cytogenet; 2008 May; 183(1):28-34. PubMed ID: 18474294
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of fluorinated analogues of SJG-136 and their DNA-binding potential.
Kamal A; Reddy PS; Reddy DR; Laxman E; Murthy YL
Bioorg Med Chem Lett; 2004 Nov; 14(22):5699-702. PubMed ID: 15482951
[TBL] [Abstract][Full Text] [Related]
15. Breed distribution of the ABCB1-1Delta (multidrug sensitivity) polymorphism among dogs undergoing ABCB1 genotyping.
Mealey KL; Meurs KM
J Am Vet Med Assoc; 2008 Sep; 233(6):921-4. PubMed ID: 18795852
[TBL] [Abstract][Full Text] [Related]
16. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever.
Tufan A; Babaoglu MO; Akdogan A; Yasar U; Calguneri M; Kalyoncu U; Karadag O; Hayran M; Ertenli AI; Bozkurt A; Kiraz S
J Rheumatol; 2007 Jul; 34(7):1540-4. PubMed ID: 17610314
[TBL] [Abstract][Full Text] [Related]
17. The effects of ABCB1 3'-untranslated region variants on mRNA stability.
Gow JM; Chinn LW; Kroetz DL
Drug Metab Dispos; 2008 Jan; 36(1):10-5. PubMed ID: 17940136
[TBL] [Abstract][Full Text] [Related]
18. Influence of adenosine triphosphate and ABCB1 (MDR1) genotype on the P-glycoprotein-dependent transfer of saquinavir in the dually perfused human placenta.
Rahi M; Heikkinen T; Hakkola J; Hakala K; Wallerman O; Wadelius M; Wadelius C; Laine K
Hum Exp Toxicol; 2008 Jan; 27(1):65-71. PubMed ID: 18480151
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter.
Park SY; Kwak W; Thapa N; Jung MY; Nam JO; So IS; Kim SY; Yoo J; Lee J; Kim IS
J Nucl Med; 2008 Sep; 49(9):1480-8. PubMed ID: 18703598
[TBL] [Abstract][Full Text] [Related]
20. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells.
Rodrigues AC; Curi R; Hirata MH; Hirata RD
Eur J Pharm Sci; 2009 Jun; 37(3-4):486-91. PubMed ID: 19394420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
